Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefits
- 28 June 2011
- journal article
- review article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 155 (3), 362-371
- https://doi.org/10.1016/j.ijcard.2011.06.012
Abstract
No abstract availableKeywords
Funding Information
- Sanofi US
This publication has 80 references indexed in Scilit:
- Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial)The American Journal of Cardiology, 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm ManagementCanadian Journal of Cardiology, 2011
- Ethics in the authorship and publishing of scientific articlesInternational Journal of Cardiology, 2010
- Atrial‐selective sodium channel block as a novel strategy for the management of atrial fibrillationAnnals of the New York Academy of Sciences, 2010
- Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAmerican Heart Journal, 2008
- Pharmacotherapy for atrial arrhythmias: Present and futureHeart Rhythm, 2008
- Amiodarone versus Sotalol for Atrial FibrillationThe New England Journal of Medicine, 2005
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionThe New England Journal of Medicine, 1999
- Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutterThe American Journal of Cardiology, 1996
- Electrophysiologic properties of flecainide acetateThe American Journal of Cardiology, 1984